Miami (November 13, 2025) – Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD and allow for more timely interventions ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease (COPD), are the fifth-leading cause of death in the United States. A contributing factor is diagnostic ...

Pulmonary Function Testing Devices Market size was valued at $1.9 billion in 2021, and is estimated to reach $3.5 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031. Pulmonary function ...

A pulmonologist discusses the history and influence of race-based reference equations in pulmonary function testing interpretation and patient care.